Lung cancer - small cell

Small cell lung cancer, often shortened to SCLC, is one of the two main types of lung cancer. The other is non-small cell lung cancer. “Small cell” describes how the cancer cells look under a microscope. It does not mean that the cancer or lung tumour is small.

SCLC usually begins in the breathing tubes within the lungs. It is a type of neuroendocrine cancer, meaning that it develops from cells with features of both nerve cells and hormone-producing cells.

This cancer tends to grow and spread more quickly than most non-small cell lung cancers. It may spread to lymph nodes, the brain, liver, bones, adrenal glands, or the other lung. For this reason, assessment and treatment usually begin promptly after diagnosis.

Doctors often describe SCLC as either:

• Limited-stage: confined to one side of the chest and nearby areas that can usually be included in one radiotherapy treatment area
• Extensive-stage: spread beyond that area, including to distant organs or the other lung

A more detailed system called TNM staging may also be used. It records the tumour’s size, whether lymph nodes are involved, and whether the cancer has spread elsewhere.

Symptoms may come from the tumour in the lung, pressure on nearby structures, or cancer that has spread. Some people have few symptoms at first.

Common symptoms include:

• A new cough or a cough that does not settle
• A change in a long-standing cough
• Shortness of breath or noisy breathing
• Chest or shoulder pain
• Coughing up blood
• Repeated chest infections
• A hoarse voice
• Unexplained weight loss, poor appetite, or marked tiredness

A tumour near the top of the chest can sometimes press on a large vein called the superior vena cava. This may cause swelling of the face, neck, or arms, prominent veins on the chest, headache, or worsening breathlessness.

SCLC can occasionally release hormone-like substances or trigger an immune reaction affecting other parts of the body. These are called paraneoplastic syndromes. They may cause muscle weakness, confusion, low blood sodium, changes in blood pressure, or unusual weight gain and bruising.

These symptoms can have many causes other than cancer. New, persistent, or worsening symptoms still need medical assessment.

SCLC develops when genetic damage causes lung cells to grow without normal control. In most cases, this damage is strongly linked to tobacco smoke.

Cigarette smoking is the main risk factor. Risk generally rises with the amount smoked and the number of years a person has smoked. People who have stopped smoking can still develop SCLC, but stopping lowers future lung cancer risk and has health benefits at any age.

Other possible risk factors include long-term exposure to second-hand smoke, radon gas, asbestos, diesel exhaust, and certain workplace substances such as arsenic, chromium, or nickel compounds. More than one exposure may contribute.

SCLC is uncommon in people who have never smoked, but it can occur. Having the condition does not mean that someone is to blame. Cancer develops through a complex combination of cell changes and exposures that cannot always be identified in one person.

Diagnosis usually begins with a medical history, examination, and chest imaging. A chest X-ray may find an abnormal area, but a CT scan gives more detailed information about the lungs, lymph nodes, and nearby structures.

A tissue sample, called a biopsy, is needed to confirm SCLC. The sample may be collected during bronchoscopy, when a thin flexible camera is passed through the mouth or nose into the airways. It may instead be taken through the chest wall with imaging guidance or from an involved lymph node or another affected area.

A pathologist examines the cells under a microscope and may use laboratory stains to confirm their type. This distinguishes SCLC from other lung cancers that require different treatment.

Further tests establish the stage and help plan treatment. They may include:

• CT scans of the chest and abdomen
• PET-CT to look for active cancer in the body
• MRI of the brain
• Blood tests to check blood counts and organ function
• Lung and heart tests when radiotherapy or surgery is being considered

The team also considers your general health, everyday activity, other medical conditions, and treatment preferences. These factors can affect which options are suitable.

Treatment is planned by a team that may include cancer doctors, chest specialists, radiologists, surgeons, specialist nurses, and symptom-control professionals.

Chemotherapy is central to treating SCLC because the cancer may have travelled beyond what scans can show. It uses medicines that circulate through the body and damage cancer cells. Platinum-based chemotherapy combined with another chemotherapy medicine is commonly used.

For limited-stage SCLC, chemotherapy and chest radiotherapy are often given during the same treatment period. Radiotherapy uses focused high-energy beams to damage cancer cells. Giving both treatments together can improve cancer control, but it may also increase short-term side effects, so it is not suitable for everyone.

Surgery has a limited role because SCLC often spreads early. It may be considered when a very small tumour appears confined to one lung without lymph-node involvement. Detailed staging is needed first, and chemotherapy is generally considered after surgery.

For extensive-stage SCLC, initial treatment commonly combines chemotherapy with immunotherapy. Immunotherapy helps the immune system recognise and attack cancer cells. Some people continue immunotherapy after chemotherapy ends. Chest radiotherapy may be considered in selected situations.

Because SCLC can spread to the brain, preventive brain radiotherapy, called prophylactic cranial irradiation, may be discussed after a good response to treatment. It can reduce the chance of brain metastases but has potential effects on memory, concentration, and tiredness. Regular brain MRI monitoring may be an alternative in some circumstances.

SCLC can return after responding to treatment. Further treatment may include different chemotherapy, an approved targeted cancer medicine, radiotherapy for a specific area, or a clinical trial. The choice is influenced by previous treatment, how long the response lasted, where the cancer has returned, and your overall health.

Supportive and palliative care can be provided at any stage. It helps manage breathlessness, pain, nausea, tiredness, anxiety, appetite problems, and treatment side effects. Palliative care can be given alongside cancer treatment and does not mean that treatment has stopped.

SCLC may block an airway, causing breathlessness, collapse of part of a lung, or repeated infection. Fluid can collect around the lung, known as a pleural effusion, and make breathing more difficult.

Cancer that spreads to bone may cause pain or weaken the bone. Brain involvement can cause headaches, seizures, confusion, balance problems, or weakness. Liver involvement may affect appetite, energy, or liver function.

Superior vena cava obstruction can occur when a chest tumour presses on the main vein returning blood from the upper body. New facial or neck swelling with breathlessness needs urgent assessment.

Treatment can also cause complications. Chemotherapy may lower infection-fighting white blood cells, while chest radiotherapy may irritate the swallowing tube or inflame lung tissue. Immunotherapy can sometimes cause the immune system to inflame healthy organs. Your cancer team should explain which symptoms need immediate contact.

SCLC cannot always be prevented. The most effective way to reduce risk is not to smoke. If you smoke, stopping still lowers future risk and may improve breathing, treatment tolerance, and recovery.

Support may include counselling, stop-smoking services, and approved nicotine or other medicines. A healthcare professional can help you choose an approach suited to your circumstances.

Reducing exposure to second-hand smoke and testing homes for radon where this is relevant may also lower risk. Workplace safety measures are important when jobs involve asbestos, diesel exhaust, or other lung carcinogens.

Low-dose CT screening can find lung cancer before symptoms develop in some people with a substantial smoking history. Screening does not prevent cancer and is not suitable for everyone. Eligibility is based on factors such as age and smoking history and differs between screening programmes.

SCLC often shrinks noticeably with initial treatment, and symptoms may improve. However, the condition frequently returns, especially when it was extensive at diagnosis. No test can predict one person’s course with certainty.

During treatment, you may have regular blood tests, clinic visits, and scans. After treatment, follow-up focuses on recovery, symptoms, treatment effects, and signs that the cancer has returned. Brain imaging may form part of follow-up when preventive brain radiotherapy has not been used.

Tiredness can continue for weeks or months. Chest radiotherapy may temporarily make swallowing painful, and some people notice longer-term breathlessness. Brain treatment can affect memory or concentration. Report these changes rather than assuming they must be tolerated; rehabilitation, medicines, nutrition support, or practical adjustments may help.

Many people continue everyday activities, relationships, and valued routines, although plans may need to change around treatment and energy levels. Gentle activity, rest, adequate food and fluids, and help with transport or household tasks can make treatment periods more manageable.

The emotional impact may include fear, sadness, anger, or uncertainty. Specialist nurses, counsellors, support groups, and palliative care teams can provide practical and emotional support. Planning future care can also help you record what matters to you without taking away hope or ongoing treatment choices.

Arrange a routine medical appointment for a persistent or changing cough, unexplained breathlessness, repeated chest infections, chest pain, weight loss, or worsening tiredness. These symptoms do not necessarily mean cancer, but they should be assessed.

If you have already been diagnosed, contact your cancer team promptly about new or worsening symptoms, including increasing pain, difficulty swallowing, new headaches, balance changes, confusion, weakness, or treatment side effects.

Seek urgent same-day medical help for:

• Any new coughing up of blood
• New swelling of the face, neck, or arms
• Sudden weakness, confusion, or a severe new headache
• Fever or signs of infection during chemotherapy
• Rapidly worsening breathlessness

Call emergency services for severe difficulty breathing, coughing up more than a small streak of blood, a seizure, collapse, or chest pain with fainting or severe weakness.

Follow any emergency instructions and contact numbers supplied by your cancer team. During chemotherapy, their advice may use a specific temperature threshold.

Is small cell lung cancer curable?

Sometimes. Cure is most possible when the cancer is limited to the chest and responds well to combined treatment. Even then, it can return. Extensive-stage SCLC is usually treated to control the cancer, reduce symptoms, and help people live longer rather than with an expectation of cure.

How fast does small cell lung cancer spread?

It often grows and spreads faster than non-small cell lung cancer. This is why staging and treatment are usually organised promptly. Fast growth can also make SCLC sensitive to chemotherapy and radiotherapy, particularly during initial treatment.

Why is surgery rarely used?

By the time SCLC is found, cancer cells have often reached lymph nodes or other parts of the body. Treatment that travels through the bloodstream is therefore usually more useful than removing one lung tumour. Surgery may be an option for a small, very early cancer after thorough staging.

What is the difference between limited and extensive stage?

Limited-stage cancer is restricted to an area that can generally be treated within one chest radiotherapy field. Extensive-stage cancer has spread beyond that area. The distinction helps guide treatment, although doctors may also describe the cancer using the detailed TNM system.

Can small cell lung cancer come back after treatment?

Yes. SCLC can return in the lung, chest, brain, or another organ, even after a strong initial response. Follow-up and prompt reporting of new symptoms help identify changes. Further treatment may still be possible.

Does stopping smoking help after diagnosis?

Yes. Stopping can improve breathing and circulation, reduce the risk of infection and other cancers, and may help the body cope with treatment. Support is available even if you have tried to stop before.